Scope of Australia/EU MRA (mutual recognition agreement) to be extended:
This article was originally published in Clinica
Experts involved in negotiating the mutual recognition agreement (MRA) between the EU and Australia have decided that they must now convene the MRA joint committee to amend the agreement to include IVDs and some higher risk devices.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.